Apple, FitBit among 9 companies selected for FDA pre-cert program

The FDA selected nine digital health companies for participation in its pre-certification pilot program, FDA Commissioner Scott Gottlieb, MD, announced in a keynote address at the AdvaMed MedTech Conference in San Jose, Calif., Sept. 26.

The agency's Pre-Cert for Software Pilot Program — part of the FDA's Digital Health Innovation Action Plan — will streamline FDA approvals for digital health technologies by reviewing developers rather than their individual products.

"We need to modernize our regulatory framework so that it matches the kind of innovation we're being asked to evaluate, and helps foster beneficial technology while ensuring that consumers have access to high-quality, safe and effective digital health devices," Dr. Gottlieb said.

To participate in the pilot program participants must provide the FDA insights on how they develop, test and maintain their software products, as well as how they collect post-market data.

Here are the nine FDA pre-certified digital health companies, listed in alphabetical order.

1. Cupertino, Calif.-based Apple

2. San Francisco-based Fitbit

3. New Brunswick, N.J.- based Johnson & Johnson

4. Boston-based Pear Therapeutics

5. New York City-based Phosphorus

6. Basel, Switzerland-based Roche

7. Seoul, South Korea-based Samsung

8. Palo Alto, Calif.-based Tidepool

9. Mountain View, Calif.-based Verily

More articles on supply chain:

How this movie studio is challenging blood draw restrictions

Why pharmaceutical products in the US don't include braille labeling

Abbott earns FDA approval for MRI-compatible defibrillator

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months